適用於公開取用強制性政策的文章 - Mutasem Taha瞭解詳情
未在任何資料庫公開的文章：5
Simulated annealing molecular dynamics and ligand–receptor contacts analysis for pharmacophore modeling
MH Ma'mon, MO Taha
Future Medicinal Chemistry, 2017
授權規定： National Natural Science Foundation of China
Discovery of New Gyrase β Inhibitors Via Structure Based Modeling
AH Al-Nadaf, SA Salah, MO Taha
Computational Biology and Chemistry, 2018
授權規定： US National Institutes of Health
Elaboration of novel TTK1 inhibitory leads via QSAR-guided selection of crystallographic pharmacophores followed by in vitro assay
MA Al-Sha’er, MO Taha
Current Computer-Aided Drug Design 17 (4), 511-522, 2021
授權規定： US National Institutes of Health
Investigation of binding characteristics of Phosphoinositide-dependent kinase-1 (PDK1) co-crystallized ligands through virtual pharmacophore modeling leading to novel anti-PDK1 …
IA Mansi, MA Al-Sha'er, NM Mhaidat, MO Taha, R Shahin
Medicinal Chemistry 16 (7), 860-880, 2020
授權規定： US National Institutes of Health
Ligand based pharmacophore modeling followed by biological screening lead to discovery of novel PDK1 inhibitors as anticancer agents
I Mansi, MA Al-Sha'er, N Mhaidat, M Taha
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2020
授權規定： US National Institutes of Health
在某個資料庫公開的文章：12
Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2
MM Hatmal, W Alshaer, MAI Al-Hatamleh, M Hatmal, O Smadi, MO Taha, ...
Cells 9 (12), 2638, 2020
授權規定： National Health and Medical Research Council, Australia
Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis
MA Al-Sha’er, MA Khanfar, MO Taha
Journal of molecular modeling 20, 1-15, 2014
授權規定： US National Institutes of Health
Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis
MO Taha, MA Al-Sha'er, MA Khanfar, AH Al-Nadaf
European journal of medicinal chemistry 84, 454-465, 2014
授權規定： US National Institutes of Health
Combining docking-based comparative intermolecular contacts analysis and k-nearest neighbor correlation for the discovery of new check point kinase 1 inhibitors
NJ Jaradat, MA Khanfar, M Habash, MO Taha
Journal of Computer-Aided Molecular Design, 1-21, 2015
授權規定： US National Institutes of Health
Computational modeling of the bat HKU4 coronavirus 3CLpro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory …
A Abuhammad, RA Al‐Aqtash, BJ Anson, AD Mesecar, MO Taha
Journal of Molecular Recognition 30 (11), e2644, 2017
授權規定： US National Science Foundation, US National Institutes of Health
Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores
MA Al-Sha’er, HA Basheer, MO Taha
Molecular Diversity 27 (1), 443 - 462, 2023
授權規定： US National Institutes of Health
Discovery of New Phosphoinositide 3-kinase Delta (PI3Kδ) Inhibitors via Virtual Screening using Crystallography-derived Pharmacophore Modelling and QSAR Analysis
MA Al-Sha'er, A Rua’a, MO Taha
Medicinal Chemistry 15, 1-14, 2019
授權規定： US National Institutes of Health
Ligand-based modeling of Akt3 lead to potent dual Akt1/Akt3 inhibitor
MA Al-Sha’er, MO Taha
Journal of Molecular Graphics and Modelling 83, 153-166, 2018
授權規定： US National Institutes of Health
Development of phosphoinositide 3-kinase delta (PI3Kδ) inhibitors as potential anticancer agents through the generation of ligand-based pharmacophores and biological screening
MA Al-Sha’er, M Taha, MA Alelaimat
Medicinal chemistry research 17, 30, 2023
授權規定： US National Institutes of Health
Discovery of novel potent nuclear factor kappa‐B inhibitors (IKK‐β) via extensive ligand‐based modeling and virtual screening
MA Al‐Sha'er, IS Almazari, MO Taha
Journal of Molecular Recognition 30 (6), e2604, 2017
授權規定： US National Institutes of Health
Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors
MA Khanfar, MO Taha
Journal of Molecular Recognition 30 (9), e2623, 2017
授權規定： US National Institutes of Health
Discovery of check point kinase 1 (Chk1) inhibitors as potential anticancer agents using ligand-based modelling and virtual screening
MA Al-Sha’er, MA Khanfar, MO Taha
J Sil Vitro Pharmacol 1, 1-11, 2015
授權規定： US National Institutes of Health
出版品和資金資訊是由電腦程式自動估算而得